CVAC Stock (CureVac) German Biotech IPO

lesson / review

Founded in 2000 and is headquartered in Tubingen, Germany

CureVac raised more than $213 million in its IPO. That is on top of the $640 million in financing the company raised in a private round that closed in July.

CVAC says its Phase 3 trial for a Covid-19 vaccine will publish results in Q4 2020 and the IPO enjoys strong investor support.

30% German Gov

Bill Gates

1) https://finviz.com/quote.ashx?t=cvac

2) https://www.barrons.com/articles/german-biotech-curevac-stock-covid-vaccine-messsengre-rna-51597669690?siteid=yhoof2

 

What's your play for $CVAC??

https://youtu.be/eCFwZ5_3Cg8

 

Table of Contents
  • Loading TOC...



Back to the post list  ⋅  0 comments have been posted.
Sample Toast 11 mins ago
tradejournal test feature
// Trigger Modal After 5 Seconds & Check For localStorage to see if it's shown the popup in the last 60min